CONMED Corp
For the period ended May 20, 2025. Filed Apr 8, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 20, 2025 · Filed Apr 8, 2025
Contents
Pay Versus Performance
The Company’s executive compensation has been highly correlated with the Company’s performance. Each year, the Compensation Committee assesses the performance of the Company over time, the prior year’s performance, as well as the anticipated performance in the coming year to determine the appropriate level of compensation.
The Pay versus Performance table below shows the strong link between Compensation Actually Paid (“CAP”) and the performance of the Company. The strong correlation between TSR and CAP results from two factors: (i) the role of revenue growth and adjusted diluted net earnings per share in driving the executive bonus plan payouts; and (ii) the fact that our NEOs do not realize value from stock options unless stockholders also see an increase in the stock price, which is the sole driver of value for the stock options (as we do not allow for dividend equivalents for unvested stock options). The Company added PSUs to its long-term incentive compensation program in 2023. These PSUs will be earned and vest based on the relative performance of the Company’s TSR compared to an index of similar companies.
| Value of Initial Fixed $100 Investment Based On: | ||||||||
|---|---|---|---|---|---|---|---|---|
| FiscalYear | Summary Compensation Table (SCT) Total for PEO(1) | Compensation Actually Paid to PEO(2) | Average Summary Compensation Table Total for Non-PEO NEOs(1) | Average Compensation Actually Paid to Non-PEO NEOs(3) | Total Shareholder Return(4) | Peer Group Total Shareholder Return(4) | Net Income(in $M) | Adjusted Diluted Net Earnings Per Share(5) |
| (a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) |
| 2024 | $7,366,555 | ($4,765,014) | $2,766,144 | ($45,286) | $63.84 | $137.81 | $132.4 | $4.17 |
| 2023 | $7,764,615 | $13,280,569 | $2,498,754 | $3,900,605 | $101.04 | $124.22 | $64.5 | $3.45 |
| 2022 | $7,835,495 | ($8,291,607) | $3,060,984 | ($792,323) | $81.19 | $113.92 | ($80.6) | $2.65 |
| 2021 | $9,374,480 | $23,174,447 | $2,345,015 | $5,176,896 | $128.81 | $140.40 | $62.5 | $3.21 |
| 2020 | $6,461,620 | $8,417,084 | $1,706,722 | $2,092,471 | $101.14 | $117.63 | $9.5 | $2.18 |
| (1) | The PEO and Non-PEO NEOs included in the above compensation reflect the following: |
| Fiscal Year | PEO | Non-PEO NEOs |
| 2024 | Curt R. Hartman | Todd W. Garner, Patrick J. Beyer, Stanley (Bill) W. Peters, Heather L. Cohen,Peter Shagory, Brent Lalomia |
| 2023 | Curt R. Hartman | Todd W. Garner, Patrick J. Beyer, Stanley (Bill) W. Peters, Heather L. Cohen |
| 2022 | Curt R. Hartman | Todd W. Garner, Patrick J. Beyer, Stanley (Bill) W. Peters, Heather L. Cohen |
| 2021 | Curt R. Hartman | Todd W. Garner, Patrick J. Beyer, Stanley (Bill) W. Peters, Daniel S. Jonas |
| 2020 | Curt R. Hartman | Todd W. Garner, Patrick J. Beyer, John E. (Jed) Kennedy, Stanley (Bill) W. Peters |
| 2025 Proxy Statement | 61 |
|---|
| (2) | The following table sets forth the adjustments made to the SCT Total for the PEO during each year presented to determine compensation actually paid (CAP) to the PEO, with “fair value” calculated in accordance with FASB ASC Topic 718, Compensation – Stock Compensation, as of the end of the specified period. |
| Fiscal Year | 2024 |
|---|---|
| SCT Total | $7,366,555 |
| Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year | ($5,314,742) |
| Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year | $4,032,496 |
| Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years | ($8,134,626) |
| Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year | $0 |
| Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year | ($2,714,697) |
| Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year | $0 |
| Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation | $0 |
| Compensation Actually Paid | ($4,765,014) |
| (3) | The following table sets forth the adjustments made to the SCT Total for Non-PEO NEOs during each year presented to determine compensation actually paid (CAP) to Non-PEO NEOs, with “fair value” calculated in accordance with Compensation – Stock Compensation Topic 718 of FASB ASC as of the end of the specified period. |
| Fiscal Year | 2024 |
|---|---|
| SCT Total | $2,766,144 |
| Exclusion of Change in Pension Value | $0 |
| Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year | ($1,849,840) |
| Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year | $1,324,143 |
| Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years | ($1,360,395) |
| Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year | $0 |
| Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year | ($505,872) |
| Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year | ($419,466) |
| Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation | $0 |
| Compensation Actually Paid | ($45,286) |
| (4) | Pursuant to Item 402(v) of Regulation S-K,, each year reflects what the cumulative value of $100 would be, including the reinvestment of dividends, if such amount were invested on December 31, 2019. The Peer Group referenced for purposes of TSR comparisons reflects the group of companies in the S&P 500 Health Care Equipment Index, which is the industry peer group as reflected in our Annual Report on Form 10-K pursuant to Item 201(e) of Regulation S-K for the fiscal year ended December 31, 2024. |
| 62 | 2025 Proxy Statement |
| (5) | Adjusted diluted net earnings per share (“EPS”) is a financial measure that the Company believes is an important performance measure to link compensation actually paid to our PEO and non-PEO NEOs to the Company’s performance. Adjusted diluted net EPS is a non-GAAP measure. Refer to the “GAAP to Non-GAAP Reconciliations” section of this proxy statement for the most directly comparable GAAP measure, GAAP diluted earnings (loss) per share. |
Most Important Performance Measures
The table below lists our most important performance measures used to link compensation actually paid to our NEOs for 2024 to Company performance, as further described in the sections titled “2024 Executive Bonus Plan” and “2024 Equity Compensation” of the CD&A.
| 2024 Most Important Performance Measures (Unranked) | |
|---|---|
| • Revenue | • Operating Cash Flow |
| • Adjusted Diluted Net Earnings per Share | • Three-year relative shareholder return |
Relationship Between Compensation and Financial Performance
The table below shows the alignment between Compensation Actually Paid (CAP) to our CEO and Average CAP to the
non-CEO
NEOs, and our performance, consistent with our compensation philosophy as described in our “Compensation Discussion and Analysis.” The following graph displays CONMED TSR, Peer Group TSR, the CAP for our PEO and the average
non-PEO
NEO CAP, for the years 2020, 2021, 2022, 2023, and 2024.
| 2025 Proxy Statement | 63 |
|---|
The following graph displays Net Income and CAP of our PEO and the average
non-PEO
NEOs for the years 2020, 2021, 2022, 2023, and 2024.
The following graph displays our Company selected measure, Adjusted Diluted Net EPS, and the CAP for our PEO and the average
non-PEO
NEO CAP for the years 2020, 2021, 2022, 2023, and 2024.
| 64 | 2025 Proxy Statement |
Board of Directors and Compensation Committee Interlocks and Insider Participation; Certain Relationships and Related Transactions
The Company’s Board of Directors, which is presently composed of Patrick Beyer, David Bronson, Brian P. Concannon, LaVerne Council, Charles M. Farkas, Martha Goldberg Aronson, Mark Kaye, Barbara J. Schwarzentraub and John L. Workman, establishes the compensation plans and specific compensation levels previously for Mr. Hartman in his role as President and CEO, for Mr. Beyer in his role as President and CEO and for other executive officers through the Compensation Committee, and administers the Company’s equity incentive plans through the Compensation Committee. Mr. Hartman did not, and Mr. Beyer does not, participate in any deliberations or voting of the Compensation Committee or Board regarding CEO compensation. During the year ended December 31, 2024, Brian Concannon, LaVerne Council, Charles Farkas, Jerome Lande, and John Workman served as members of our Compensation Committee. No member of our Compensation Committee is or has been an officer or employee of the Company. No member of our Compensation Committee or our Board is or has been in 2024 an executive officer of another entity at which one of our executive officers serves or has in 2024 served on either the Board of Directors or Compensation Committee.
In March 2003, the Audit Committee adopted a written policy specifying that it wouldpre-approve all transactions in which the Company is a participant and in which a related person has or will have a direct or indirect material interest, including, without limitation, any financial transaction, arrangement or relationship (including any indebtedness or guarantee of indebtedness) or any series of similar transactions, arrangements or relationships, other than related party transactions to any person or entity that are, individually or in the aggregate on an annual basis, more than $5,000. This was reaffirmed in the Audit Committee Charter adopted as of December 2024. Pursuant to the related-party policy, which the Audit Committee reviews annually, requests forpre-approvals can be submitted to the Chair of the Audit Committee forpre-approval, with the Chair to report any suchpre-approvals at the next scheduled meeting of the Audit Committee. Under the policy, such related-person transactions as further defined in the Company’s related-party policy must be approved or ratified by the Audit Committee. Further, any related-party transaction in which the projected spending is over $50,000 requires management to secure competitive bids to ensure that any proposal is reasonable with respect to costs. The Audit Committee may also determine that the approval or ratification of such transaction should be considered by all the disinterested members of the Board. Related persons include any of our directors or executive officers and their family members.
In considering whether to approve or ratify any related-person transaction, the Chair or Audit Committee, as applicable, may consider all factors that they deem relevant to the transaction, including, but not limited to: the size of the transaction and the amount payable to or receivable from a related person; the nature of the interest of the related person in the transaction; the Company’s prior dealings, if any, with the related party; whether the transaction may involve a conflict of interest; and whether the transaction involves the provision of goods or services to the Company that are available from unaffiliated third parties and, if so, whether the transaction is on terms and made under circumstances that are at least as favorable to the Company as would be available in comparable transactions with or involving unaffiliated third parties.
To identify related-person transactions, at least once a year, all directors and executive officers of the Company are required to complete questionnaires seeking, among other things, disclosure with respect to such transactions of which such director or executive officer may be aware.
The Company employs Devon Hartman, who is thedaughter-in-law of Mr. Hartman, as a product manager. As such, she is paid a salary and is enrolled in the Employee Incentive Program at a rate commensurate with others in similar positions within the company with similar performance and experience levels. In addition, she is eligible to participate in other compensation programs, such as the Retirement Savings Plan, on the same terms available to all other employees. During 2024, she earned total compensation of $151,001.18.
| 2025 Proxy Statement | 65 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.